SE9801494D0 - Novel use - Google Patents
Novel useInfo
- Publication number
- SE9801494D0 SE9801494D0 SE9801494A SE9801494A SE9801494D0 SE 9801494 D0 SE9801494 D0 SE 9801494D0 SE 9801494 A SE9801494 A SE 9801494A SE 9801494 A SE9801494 A SE 9801494A SE 9801494 D0 SE9801494 D0 SE 9801494D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel use
- relates
- inflammatory agents
- pharmaceutical compounds
- certain pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (30)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801494A SE9801494D0 (sv) | 1998-04-28 | 1998-04-28 | Novel use |
ARP990101817A AR016212A1 (es) | 1998-04-28 | 1999-04-20 | Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas |
MYPI99001635A MY121063A (en) | 1998-04-28 | 1999-04-27 | Use of nmda antagonists for treatment of irritable bowel syndrome |
KR1020007011958A KR100569777B1 (ko) | 1998-04-28 | 1999-04-28 | 과민성 대장 증후군의 치료를 위한 nmda 길항제의 용도 |
ES99947024T ES2221753T3 (es) | 1998-04-28 | 1999-04-28 | Uso de antagonistas de nmda para el tratamiento del sindrome del colon irritable. |
PCT/SE1999/000701 WO1999055322A1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
AT99925537T ATE271861T1 (de) | 1998-04-28 | 1999-04-28 | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen |
IL13891999A IL138919A0 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists for treatment of irritable bowel syndrome |
AT99947024T ATE270545T1 (de) | 1998-04-28 | 1999-04-28 | Verwendung von nmda antagonisten zur behandlung des reizkolons |
DE69918541T DE69918541T2 (de) | 1998-04-28 | 1999-04-28 | Verwendung von nmda antagonisten zur behandlung des reizkolons |
CNB998078182A CN1200702C (zh) | 1998-04-28 | 1999-04-28 | Nmda拮抗剂用于治疗过敏性肠综合征的用途 |
SI9930647T SI1073431T1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists for treatment of irritable bowel syndrome |
JP2000545521A JP2002512955A (ja) | 1998-04-28 | 1999-04-28 | 炎症疾患の治療のためのnmdaアンタゴニストおよび/またはナトリウムチャンネルアンタゴニストの使用 |
BR9909971-3A BR9909971A (pt) | 1998-04-28 | 1999-04-28 | Uso de um composto, processo para tratamento ou prevenção da sìndrome de intestinos irritáveis, e, composição farmacêutica para o tratamento da sìndrome dos intestinos irritáveis |
US09/380,988 US6221887B1 (en) | 1998-04-28 | 1999-04-28 | Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists |
DE69918972T DE69918972T2 (de) | 1998-04-28 | 1999-04-28 | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen |
AU41793/99A AU4179399A (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
EP99947024A EP1073431B1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists for treatment of irritable bowel syndrome |
PT99947024T PT1073431E (pt) | 1998-04-28 | 1999-04-28 | Utlizacao de antagonistas de nmda no tratamento da sindroma do intestino irritavel |
NZ507436A NZ507436A (en) | 1998-04-28 | 1999-04-28 | Use of NMDA antagonists for treatment of irritable bowel syndrome (IBS) and compounds with NMDA receptor antagonistic properties |
EP99925537A EP1073430B1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
CA002329328A CA2329328A1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists for treatment of irritable bowel syndrome |
PCT/SE1999/000702 WO1999055323A1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists for treatment of irritable bowel syndrome |
JP2000545522A JP2002512956A (ja) | 1998-04-28 | 1999-04-28 | 過敏性腸症候群の治療のためのnmdaアンタゴニストの使用 |
AU43024/99A AU760783B2 (en) | 1998-04-28 | 1999-04-28 | Use of NMDA antagonists for treatment of irritable bowel syndrome |
DK99947024T DK1073431T3 (da) | 1998-04-28 | 1999-04-28 | Anvendelse af NMDA-antagonister til behandling af irritabel tarmsyndrom |
TW088113888A TW570793B (en) | 1998-04-28 | 1999-08-13 | Pharmaceutical composition comprising an NMDA antagonist for treating irritable bowel syndrome |
SA99200482A SA99200482B1 (ar) | 1998-04-28 | 1999-08-17 | استخدام مضادات nmda في علاج متلازمة المعدة التهيجية irritable bowel syndrome |
NO20005386A NO20005386D0 (no) | 1998-04-28 | 2000-10-26 | Anvendelse av NMDA-antagonister for behandling av irritabel tarmsyndrom |
HK01104450A HK1033876A1 (en) | 1998-04-28 | 2001-06-27 | Use of nmda antagonists for treatment of irritablebowel syndrome. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801494A SE9801494D0 (sv) | 1998-04-28 | 1998-04-28 | Novel use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9801494D0 true SE9801494D0 (sv) | 1998-04-28 |
Family
ID=20411120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9801494A SE9801494D0 (sv) | 1998-04-28 | 1998-04-28 | Novel use |
Country Status (8)
Country | Link |
---|---|
US (1) | US6221887B1 (sv) |
EP (1) | EP1073430B1 (sv) |
JP (1) | JP2002512955A (sv) |
AT (1) | ATE271861T1 (sv) |
AU (1) | AU4179399A (sv) |
DE (1) | DE69918972T2 (sv) |
SE (1) | SE9801494D0 (sv) |
WO (1) | WO1999055322A1 (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003081872A (ja) * | 2001-09-13 | 2003-03-19 | Nippon Oruganon Kk | 掻痒治療薬 |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
GB0221956D0 (en) * | 2002-09-20 | 2002-10-30 | Novartis Ag | Organic compounds |
SI1658062T1 (sl) * | 2003-08-25 | 2010-05-31 | Newron Pharm Spa | Alfa aminoamidni derivati uporabni kot protivnetna sredstva |
EP1809271B9 (en) * | 2004-09-10 | 2010-09-22 | Newron Pharmaceuticals S.p.A. | Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
WO2007071311A1 (en) | 2005-12-22 | 2007-06-28 | Newron Pharmaceuticals S.P.A. | 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
CA2737335C (en) | 2008-12-19 | 2013-10-01 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類 |
WO2019190823A1 (en) | 2018-03-28 | 2019-10-03 | Vtv Therapeutics Llc | Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
WO2019190822A1 (en) | 2018-03-28 | 2019-10-03 | Vtv Therapeutics Llc | Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
JP7464591B2 (ja) | 2018-10-10 | 2024-04-09 | ブイティーブイ・セラピューティクス・エルエルシー | [3-(4-{2-ブチル-1-[4-(4-クロロ-フェノキシ)-フェニル]-1h-イミダゾール-4-イル}-フェノキシ)-プロピル]-ジエチル-アミンの代謝産物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538993A (en) * | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
US5635530A (en) * | 1991-09-12 | 1997-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them |
ZA932761B (en) | 1992-04-28 | 1993-10-28 | Battelle Memorial Institute | Diamine derivatives and application thereof in therapeutic fields |
CA2115792C (en) | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
-
1998
- 1998-04-28 SE SE9801494A patent/SE9801494D0/sv unknown
-
1999
- 1999-04-28 US US09/380,988 patent/US6221887B1/en not_active Expired - Fee Related
- 1999-04-28 AU AU41793/99A patent/AU4179399A/en not_active Abandoned
- 1999-04-28 DE DE69918972T patent/DE69918972T2/de not_active Expired - Fee Related
- 1999-04-28 AT AT99925537T patent/ATE271861T1/de not_active IP Right Cessation
- 1999-04-28 EP EP99925537A patent/EP1073430B1/en not_active Expired - Lifetime
- 1999-04-28 JP JP2000545521A patent/JP2002512955A/ja active Pending
- 1999-04-28 WO PCT/SE1999/000701 patent/WO1999055322A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1073430B1 (en) | 2004-07-28 |
DE69918972D1 (de) | 2004-09-02 |
WO1999055322A9 (en) | 2000-07-27 |
ATE271861T1 (de) | 2004-08-15 |
DE69918972T2 (de) | 2005-07-28 |
JP2002512955A (ja) | 2002-05-08 |
WO1999055322A1 (en) | 1999-11-04 |
AU4179399A (en) | 1999-11-16 |
EP1073430A1 (en) | 2001-02-07 |
US6221887B1 (en) | 2001-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199900373A2 (ru) | Фармацевтические композиции | |
PT1109812E (pt) | Pirrolobenzodiazepinas | |
EE200100483A (et) | Põletikuvastaste vahenditena kasutatavad ühendid | |
EA200300566A1 (ru) | Применение cci-779 в качестве противоопухолевого средства | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
TR199902400T2 (xx) | Fungusit etkinlik g�steren terkiplerin birle�imleri. | |
DK0944643T3 (da) | Oxyiminopregnancarbolactoner. | |
SE9802729D0 (sv) | Novel Compounds | |
SE9901077D0 (sv) | Novel use | |
IT1285770B1 (it) | Composti corticoidei | |
SE9801494D0 (sv) | Novel use | |
YU11401A (sh) | Lokalne farmaceutske kompozicije koje sadrže nimesulid | |
SE9804212D0 (sv) | Compounds | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
SE9903290D0 (sv) | Novel compounds | |
ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
TR200200494T2 (tr) | Yağlı asit sintazı inhibitörleri. | |
DK1073447T3 (da) | N1-modificerede glycopeptider | |
ATE305517T1 (de) | Neurotrypsin | |
HN1998000102A (es) | Composiciones solubilizadas de sertralina | |
ES2154692T3 (es) | Dihidrofarnesal. | |
ATE213236T1 (de) | Substituierte benzyloxyimino-verbindungen | |
SE0001631D0 (sv) | New use |